Pharmacokinetics of fungal (1-3)-β-D-glucans following intravenous administration in rats

International Immunopharmacology

Volumn 4, Issue 9, 2004, Pages 1209-1215

  Rice, Peter J ^a   Lockhart, Brent E ^a   Barker, Luke A ^a   Adams, Elizabeth L ^a   Ensley, Harry E ^b   Williams, David L ^a  

^a East Tennessee State University   (United States)

^b Tulane University   (United States)

Author keywords

Fungal; Glucans; Immunomodulation; Intravenous; Pharmacokinetics; Rat

Indexed keywords

BETA GLUCAN; CARBOHYDRATE; LAMINARAN; PHOSPHATE; SCLEROGLUCAN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIAL GROWTH; CLEARANCE; FUNGUS GROWTH; IMMUNOMODULATION; MALE; METHODOLOGY; MOLECULE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; STEADY STATE;

ANIMALS; AREA UNDER CURVE; BETA-GLUCANS; GLUCANS; HALF-LIFE; INJECTIONS, INTRAVENOUS; LIMULUS TEST; LINEAR MODELS; MALE; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 3142644827     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.05.013     Document Type: Article

References (26)

1. Browder W., Williams D., Pretus N., Olivero G., Enrichens F., Mao P., Franchello A. Beneficial effect of enhanced macrophage function in the trauma patient. Ann. Surg. 211:1990;605-612
2. Brown G.D., Herre J., Williams D.L., Willment J.A., Marshall A.S.J., Gordon S. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197:2003;1119-1124
3. Brown G.D., Taylor P.R., Reid D.M., Willment J.A., Williams D.L., Martinez-Pomares L., et al. Dectin-1 is a major β-glucan receptor on macrophages. J. Exp. Med. 296:2002;412
4. Chen L., Sadek M., Stone B.A., Brownlee R.T.C., Fincher G.B., Hoj P.B. Stereochemical course of glucan hydrolysis by barley (1→3)-and (1→3, 1→4)-beta-glucanases. Biochim. Biophys. Acta, Protein Struct. 1253:1995;112-116
5. Digby J., Kalbfleisch J., Glenn A., Larsen A., Browder W., Williams D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin. Diagn. Lab. Immunol. 10:2003;882-885
6. Freireich E.J., Gehan E.A., Rall D.P., Schmidt L.H., Skipper H.E. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50:1966;219-244
7. Fukuda I., Toyota T., Munakata H., Hayashi N. Partial purification of a beta-glucan-like component as a likely candidate for the Limulus factor G stimulator in the plasma of patients with hepatic failure. Jpn. J. Med. Sci. Biol. 43:1990;275-276
8. Iwama A., Yoshida M., Miwa A., Obayashi T., Sakamoto S., Miura Y. Improved survival from fungaemia in patients with haematological malignancies: analysis of risk factors for death and usefullness of early antifungal therapy. Eur. J. Haematol. 51:1993;156-160
9. Kami M., Tanaka Y., Kanda Y., Ogawa S., Masumoto T., Ohtomo K., et al. Computer tomographic scan of the chest, latex agglutination test and plasma (1-3)-β-D-glucan assay in early diagnosis of invasive pulmonary aspergillosis: a prospective study of 215 patients. Haematologica. 85:2000;745-752
10. Kohno S., Mitsutake K., Maesaki S., Yasuoka A., Miyazaki T., Kaku M., et al. An evaluation of serodiagnostic tests in patients with candidemia: beta-glucan, mannan, candida antigen by Cand-Tec and D-arabinitol. Microbiol. Immunol. 37:1993;207-212
11. Kougias P., Wei D., Rice P.J., Ensley H.E., Kalbfleisch J., Williams D.L., et al. Normal human fibroblasts express pattern recognition receptors for fungal (1→3)-β-D-glucans. Infect. Immun. 69:2001;3933-3938
12. Miura N.N., Ohno N., Aketagawa J., Tamura H., Tanaka S., Yadomae T. Blood clearance of (1→3)-beta-D-glucan in MRL lpr/lpr mice. FEMS Immunol. Med. Microbiol. 13:1996;51-57
13. Monari C., Retini C., Casadevall A., Netski D., Bistoni F., Kozel T.R., et al. Differences in outcome of the interaction between Cryptococcus neoformans glucuronoxylomannan and human monocytes and neutrophils. Eur. J. Immunol. 33:2003;1041-1051
14. Mori T., Ikemoto H., Matsumura M., Yoshida M., Inada K., Endo S., et al. Evaluation of plasma (1→3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections. Eur. J. Clin. Chem. Biochem. 35:1997;553-560
15. Mueller A., Raptis J., Rice P.J., Kalbfleisch J.H., Stout R.D., Ensley H.E., et al. The influence of glucan polymer structure and solution conformation on binding to (1→3)-β-D-glucan receptors in a human monocyte-like cell line. Glycobiology. 10:2000;339-346
16. Mueller A., Rice P.J., Ensley H.E., Coogan P.S., Kalbfleisch J.H., Kelley J.L., et al. Receptor binding and internalization of water-soluble (1→3)-beta-D-glucan biologic response modifier in two monocyte/macrophage cell lines. J. Immunol. 156:1996;3418-3425
17. Pretus H.A., Ensley H.E., McNamee R.B., Jones E.L., Browder I.W., Williams D.L. Isolation, physicochemical characterization and preclinical efficacy evaluation of soluble scleroglucan. J. Pharmacol. Exp. Ther. 257(1):1991;500-510
18. Rice P.J., Kelley J.L., Kogan G., Ensley H.E., Kalbfleisch J.H., Browder I.W., et al. Human monocyte scavenger receptors are pattern recognition receptors for (1-3)-β-D-glucans. Leukoc. Biol. 72:2002;140-146
19. Stone B.A., Clarke A.E. Chemistry and Biology of (1-3)-β-D-glucan. 1992;La Trobe Univeristy Press, Melbourne, Australia
20. Williams D.L. Overview of (1→3)-β-D-glucan immunobiology. Mediators Inflamm. 6:1997;247-250
21. Williams D.L., Ha T., Li C., Kalbfleisch J.H., Laffan J.J., Ferguson D.A. Inhibiting early activation of tissue nuclear factor-kB and nuclear factor interleukin 6 with (1→3)-β-D-glucan increases long-term survival in polymicrobial sepsis. Surgery. 126:1999;54-65
22. Williams D.L., McNamee R.B., Jones E.L., Pretus H.A., Ensley H.E., Browder I.W., et al. A method for the solubilization of a (1-3)-β-D-glucan isolated from Saccharomyces cerevisiae. Carbohydr. Res. 219:1991;203-213
23. Williams D.L., Rice P.J., Herre J., Willment J.A., Taylor P.R., Gordon S., et al. Recognition of fungal glucans by pattern recognition receptors. Recent Dev. Carbohydr. Res. 1:2003;49-66
24. Yoshida M., Obayashi T., Iwama A., Ito M., Tsunoda S., Suzuki T., et al. Detection of plasma (1→3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J. Med. Vet. Mycol. 35(5):1997;374
25. Yoshida M., Roth R.I., Grunfeld C., Feingold K.R., Levin J. Pharmacokinetics, biological effects, and distribution of (1→3)-β-D- glucan in blood and organs in rabbits. Mediators Inflamm. 6:1997;279-283
26. Yoshida M., Roth R.I., Grunfeld C., Feingold K.R., Levin J. Soluble (1-3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits. J. Lab. Clin. Med. 128:1996;103-114